Brief: IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease
22/08/2024 14:22
Aug 22 (Reuters) - IGC Pharma Inc IGC.A :
* IGC PHARMA ANNOUNCES RESEARCH DEMONSTRATING NEW MOLECULE
IGC-1C
TARGETS TAU PROTEIN IN ALZHEIMER'S DISEASE
Source text for Eikon: ID:nBwyLXf2a
Further company coverage: IGC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGC Pharma
See all newsFocus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Cannabis stocks climb after Trump signs order to ease curbs on marijuana (updated)
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Brief: IGC Pharma's Unit Enters Sale Of Assets Agreement For $2.7 Million - SEC Filing
Brief: IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment